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Invited commentary
Ways to reduce saturated fat intake
Reduction of saturated fat intake would lower the risk of
CHD, but how should this reduction be achieved?
Cis-unsaturated fatty acids or carbohydrates?
Current dietary guidelines emphasize a reduced intake of
total fat. This means that (saturated) fatty acids should be
replaced by carbohydrates. But are carbohydrates the opti-
mal replacement? High-carbohydrate diets do indeed lower
plasma LDL-cholesterol levels. However, both sugars and
complex carbohydrates lower HDL-cholesterol and increase
fasting triacylglycerol levels (Mensink & Katan, 1987, 1992)
and these effects last as long as the low-fat-high carbohydrate
diet is eaten (Ernst et al. 1980). Low HDL-cholesterol levels
are associated with increased risk of CHD (Gordon et al.
1989; Kinosian et al. 1994), and many factors that reduce
HDL-cholesterol levels, such as smoking, obesity and lack of
physical exercise increase the incidence of CHD. Although
we are not sure that diet-induced decreases in HDL increase
CHD risk, diets that lower HDL-cholesterol levels should be
viewed with caution (Katan et al. 1997).
An alternative to high-carbohydrate diets is to replace
saturated fat with cis-unsaturated oils (oils rich in the n-9
cis-monounsaturated oleic or the n-6 cis-polyunsaturated
linoleic acid, and some n-3 fatty acids) and leave the intake
of total fat the same. Replacement of saturated fatty acids
with cis-unsaturated fatty acids reduces LDL-cholesterol,
with little decrease in HDL. Cis-unsaturated fatty acids
considerably lower the total : HDL-cholesterol ratio (the
strongest predictor of CHD in observational studies; Kinosian
et al. 1994), while carbohydrates do not improve this ratio.
These effects have been well established by controlled
dietary trials (Mensink & Katan, 1992) and they are con-
firmed by the study of Williams et al. (1999) in the present
issue of the British Journal of Nutrition.
Low-fat, high-carbohydrate diets are thought to provide
benefits that offset their unfavourable effects on HDL-
cholesterol and triacylglycerol levels. One of these benefits
is weight loss. Indeed, populations that habitually consume
low-fat diets are often quite lean (Seidell, 1998). However,
controlled trials show that in affluent populations restriction
of energy from fat and replacement by carbohydrates results
in only modest reductions in body weight (Willett, 1998).
These reductions are too small to compensate for the HDL-
lowering effect of high-carbohydrate diets (Leenen et al.
1993). Also, the prevalence of obesity in the USA has
increased considerably over the past 25 years, despite a
concomitant decline in the intake of energy from fat. Thus,
restricting fat intake does not always result in weight reduc-
tion. This may hold particularly for Western societies, where
the typical low-fat food items available in the supermarket are
often high in energy. We may be fooling ourselves if we think
that foods high in carbohydrates, protein and fat replacers will
stop the oncoming worldwide epidemic of obesity.
Another proposed benefit of high-carbohydrate diets is
a reduction of cancer risk. However, the evidence that a
high fat intake causes cancer is weak (World Cancer
Research Fund/American Institute of Cancer Research,
1997; Department of Health, 1998). A high intake of n-3
fatty acids from fish may, if anything, offer some protection
(de Deckere et al. 1998), and intake of oleic acid and of
linoleic acid is not associated with cancer risk in human
subjects (Gerber, 1997; Zock & Katan, 1998). Thus, cis-
unsaturated fatty acids seem a suitable and safe replacement
for saturated fatty acids to reduce CHD risk, in particular for
people who are close to ideal body weight. Overweight
people should reduce energy intake by lowering consump-
tion of saturated fat and not replacing this with other
nutrients; they should also eat less sugar and other refined
carbohydrates.
Do different cis-unsaturated fatty acids have different
effects on risk? The n-6 cis-polyunsaturated fatty acid linoleic
acid may be somewhat more effective in improving the plasma
lipid profile (Mensink & Katan, 1992; Clarke et al. 1997) than
n-9 cis-monounsaturated oleic acid, but the impact of this
difference on CHD risk is probably small. The n-3 cis-
unsaturated fatty acids from fish (mainly eicosapentaenoic
and docosahexaenoic acids) and plant oils (a-linolenic acid)
may give additional protection, in particular against fatal CHD
(Albert et al. 1998; Hu et al. 1999). These observations need to
be tested in future studies but they do suggest that a diet high
in a variety of n-3, n-6 and n-9 cis-unsaturated fatty acids
might provide the optimum for reduction of CHD risk.
Implementation of dietary changes in the population
Controlled feeding trials (Mensink & Katan, 1992) predict
that a major reduction in saturated fat intake would lower
plasma total cholesterol by 10–15 % (Clarke et al. 1997).
However, the results of dietary intervention trials in free-
living subjects are generally disappointing (Ramsay et al.
1991; Tang et al. 1998). Targets for dietary change are
seldom achieved and the resulting reduction in cholesterol is
only 3–6 % over months (Tang et al. 1998) and even less
over years (Ramsay et al. 1991), and intensive dietary
counselling is needed to improve compliance. General
recommendations to the public without individual dietary
counselling are not very effective in lowering fat intake.
Indeed, despite educational campaigns to lower total fat
intake, the level of saturated fat intake in Europe remains
considerably higher than desired (Ministry of Agriculture,
Fisheries and Food, 1995; Ministry of Health, Welfare and
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Sports, and Ministry of Agriculture, Nature Management
and Fisheries, 1998). What can be done to attain more
substantial reductions of saturated fat intake? The paper of
Williams et al. (1999) points to some possible solutions.
Fat makes foods taste better, and diets rich in unsaturated
oils may therefore be more acceptable to consumers than
low-fat diets. Indeed, interventions that change the fatty
acid composition of the diet without changing the total fat
content are more effective than interventions that lower total
fat intake (Sacks, 1994; Tang et al. 1998). In their 4-month
intervention study in free-living subjects, Williams et al.
(1999) reduced the intake of saturated fatty acids from
some 16 % to 10 % of energy by replacing them with cis-
monounsaturated fatty acids. They achieved this by
replacing saturated fatty acids in a variety of foods with
monounsaturated fatty acids. Spreads, ‘ready meals’,
biscuits, puddings and breads were, apart from fatty acid
composition, identical for both the saturated fat and the
monounsaturated fat diet. The manufactured foods con-
tained 60 % of total daily fat intake and were of similar
quality and type as those available in British supermarkets.
The target intake of fatty acids was successfully accomplished
and the resulting reduction in total and LDL-cholesterol
was 6–10 % without a decrease in HDL-cholesterol level
(Williams et al. 1999). We cannot tell whether the subjects
would have been equally compliant to a low-fat diet or to a
longer-term monounsaturated fat diet. However, this study
emphasizes the role of the food industries in reducing
saturated fatty acid intake. If a large part of saturated fatty
acids in processed foods on supermarket shelves could be
replaced by cis-unsaturated fatty acids, consumers would
improve their plasma lipid profile and CHD risk without
any conscious effort. Food manufacturers succeeded in
developing low-trans fatty acid margarines that are also
low in saturated fat and higher in cis-unsaturated fat (Katan,
1995). Replacement of trans- and saturated fatty acids by
healthier fatty acids might also be achievable for other
foods. Replacing 40 % of saturated fatty acids in the total
food supply by cis-unsaturated fatty acids (6 % of total
energy intake in Britain) would lower CHD risk by at
least 10 % (Stampfer et al. 1991; Mensink & Katan, 1992;
Law et al. 1994). Because of the high incidence of CHD this
would mean a large gain for public health.
Replacement of saturated and trans fats by unsaturated
oils is more effective in improving the plasma lipid profile
than replacement with carbohydrates and it might be easier
to produce attractive goods high in cis-unsaturated fatty
acids than low in total fat. If such fat-modified foods are
sufficiently attractive, then they would provide an efficient
way to reduce the incidence of CHD.
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